In breast cancer, Pax-5 promotes pro-epithelial features and suppresses malignant cancer processes.
However, the molecular mechanism of this antitumor activity remains largely unknown.
This study aimed to identify the cellular roles of Pax-5-regulated miRNAs in breast cancer progression.
